Specialties – Page 6

Harnessing Precision Medicine: The APS Consortium’s National Platform for Phenotyping ARDS, Pneumonia, and Sepsis

By MedXY 07/15/2026

The APS Consortium establishes a large, prospective cohort of critically ill adults with ARDS, pneumonia, and sepsis to enable biologically based phenotyping, leveraging rich clinical data and biospecimens for improved understanding and therapeutic development.

Clinical Updates Internal Medicine news

Mosaic Loss of Y Chromosome Links to Pulmonary Decline, Emphysema, and Accelerated Epigenetic Aging in Men: A Comprehensive Review

By MedXY 07/15/2026

Mosaic loss of Y chromosome (mLOY) in men is strongly associated with diminished lung function, increased emphysema severity, and faster epigenetic aging, positioning mLOY as a novel biomarker for respiratory aging and COPD risk in males.

Diabetes & Endocrinology news Ophthalmology

Hyperreflective Abnormal Areas in Middle Retinal Layers via En Face OCT: A Novel Biomarker for Diabetic Retinopathy Risk Stratification

By MedXY 07/15/2026

Hyperreflective abnormalities in middle retinal layers detected by en face OCT improve diagnostic discrimination of referable diabetic retinopathy, offering a promising adjunct biomarker beyond clinical parameters.

AI news Ophthalmology

Artificial Intelligence Smart Eyeglasses for the Detection and Description of Stationary Objects: A Pilot Feasibility Study

By MedXY 07/15/2026

A pilot study evaluating Ray-Ban Meta AI eyeglasses demonstrated high accuracy in single object identification and moderate performance in descriptive tasks, suggesting promise for aiding individuals with low vision.

AI news Ophthalmology

A Consensus Reference Standard for AI Screening of Age-Related Macular Degeneration: What Clinicians and Developers Need to Know

By MedXY 07/15/2026

A 2026 expert consensus defines an image-based reference standard to validate AI screening algorithms for age-related macular degeneration (AMD), endorsing Beckman grading and routine OCT use while clarifying referral thresholds and areas of uncertainty.

Allergy & Immunology news Otorhinolaryngology

Bridging Subjective Symptoms and Objective Imaging in Chronic Rhinosinusitis: Impact of an Adaptive Sino-Nasal Outcome Test

By MedXY 07/15/2026

A novel adaptive Sino-Nasal Outcome Test (SNOT) yields improved correlation with computed tomography findings in chronic rhinosinusitis, enhancing clinical assessment and differentiation from allergic rhinitis.

news Otorhinolaryngology Pediatrics

Efficacy of Recurrent Laryngeal Nerve Reinnervation in Pediatric Unilateral Vocal Fold Paralysis: Insights from a Largest Single-Center Series

By MedXY 07/15/2026

Recurrent laryngeal nerve reinnervation significantly improves voice outcomes in pediatric unilateral vocal fold paralysis, with 90% of patients showing moderate to dramatic improvement. Prematurity and intubation history influence recovery quality.

Gastroenterology General Surgery news

Outcomes of Colorectal Dysplasia and Cancer in Patients with PSC-IBD Undergoing Liver Transplantation and Colectomy: Insights from a Multicenter Study

By MedXY 07/15/2026

This multicenter retrospective study examines colorectal dysplasia and malignancy outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease undergoing liver transplantation and colectomy, revealing comparable 5-year survival despite advanced disease in those transplanted first.

news Oncology Radiology

Enhancing Intraoperative Margin Assessment in Early-Stage Breast Cancer with Specimen PET-CT Imaging: Insights from the BrIMA Trial

By MedXY 07/15/2026

The BrIMA trial demonstrates that specimen PET-CT imaging significantly improves intraoperative detection of positive margins during breast-conserving surgery for early-stage breast cancer, reducing re-excision rates and enhancing surgical outcomes.

Diabetes & Endocrinology Gastroenterology news

EndoBarrier Duodenal-Jejunal Bypass Liner: A Novel Endoscopic Adjunct for Improved Glycemic Control and Weight Loss in Type 2 Diabetes with Obesity

By MedXY 07/15/2026

The ENDO trial demonstrates that the EndoBarrier duodenal-jejunal bypass liner significantly improves glycemic control and induces meaningful weight loss in patients with poorly controlled type 2 diabetes and obesity, with an acceptable safety profile.

news OB/GYN & Women’s Health Oncology

Harnessing HRD Testing and MYC Amplification to Optimize PARP Inhibitor Use in BRCA Wild-Type High-Grade Serous Ovarian Carcinoma

By MedXY 07/15/2026

This article reviews real-world data supporting homologous recombination deficiency (HRD) testing in BRCA1/2 wild-type high-grade serous carcinoma and examines MYC amplification as a promising surrogate biomarker to guide PARP inhibitor therapy.

news OB/GYN & Women’s Health Public Health

Severe Lead Poisoning During Pregnancy: Insights from a 19-Year NYC Observational Study

By MedXY 07/15/2026

This study investigates pregnant individuals in New York City with blood lead levels ≥45 mcg/dL, highlighting cultural risk factors, pregnancy outcomes, and treatment efficacy to inform clinical and public health strategies.

Gastroenterology news Pediatrics

Reclassifying Pediatric NAFLD: Insights from the Steatotic Liver Disease Framework in a Multicenter NASH CRN Study

By MedXY 07/15/2026

A multicenter study reclassifies pediatric NAFLD under the steatotic liver disease framework, revealing most children meet MASLD criteria, while highlighting alcohol and medication-related reclassifications that inform diagnosis and management.

Gastroenterology news Oncology

Long-term Risk of Hepatocellular Carcinoma After Clearance of Hepatitis B Surface Antigen

By MedXY 07/14/2026

This study evaluates the long-term incidence of liver cancer in chronic hepatitis B patients who clear hepatitis B surface antigen, finding significantly reduced cancer risk in younger patients without cirrhosis.

Neurology news

MAD-MT Score: Enhancing Patient Selection for Mechanical Thrombectomy in Distal Vessel Occlusions

By MedXY 07/14/2026

The MAD-MT score integrates clinical and procedural factors to optimize mechanical thrombectomy decisions in distal and medium vessel occlusion strokes, guiding tailored treatment and improving functional outcomes.

Neurology news Pathology & Lab Medicine/Bệnh học

Discriminating Prion Diseases from Alzheimer’s Disease Using Plasma Biomarkers: The Crucial Role of NfL/p-tau217 Ratio

By MedXY 07/14/2026

Plasma phosphorylated tau biomarkers overlap in Alzheimer’s and prion diseases, risking diagnostic confusion. The NfL/p-tau217 ratio emerges as an accurate plasma biomarker to distinguish prion diseases from Alzheimer’s, improving diagnostic precision and guiding appropriate clinical management.

Neurology news Orthopedics

Acute Neural Biomarker Elevations After Amateur Soccer Heading: Insights Into Potential Brain Injury

By MedXY 07/14/2026

This study reveals that even amateur soccer heading causes immediate, transient increases in blood biomarkers p-tau217 and S100B, indicating acute neural impact and suggesting a dose-response effect.

Allergy & Immunology Diabetes & Endocrinology news

Distinct Immune Subtypes in Type 1 Diabetes: Implications for Disease Progression and Personalized Immunotherapy

By MedXY 07/14/2026

Two immunologically distinct, age-independent subtypes of new-onset type 1 diabetes demonstrate differing progression rates and therapeutic responses, offering a path toward tailored immunotherapies.

Diabetes & Endocrinology Internal Medicine news

Next-Generation Pharmacotherapies in Obesity: Transforming Care with Precision and Multisystem Benefits

By MedXY 07/14/2026

Emerging obesity pharmacotherapies targeting entero-pancreatic hormones deliver substantial weight loss and improve multiple obesity-related complications, heralding a treat-to-target paradigm in obesity management with personalized, complication-centric care.

Diabetes & Endocrinology news

Exploring Low-Dose Antithymocyte Globulin Therapy in Type 1 Diabetes: Real-World Insights Using Modified Quantitative Response of C-Peptide

By MedXY 07/14/2026

This article examines real-world data on low-dose antithymocyte globulin in type 1 diabetes, assessing beta-cell function via a novel C-peptide modified quantitative response (mQR). Findings suggest feasibility, safety, and potential clinical benefit in preserving endogenous insulin secretion.